Dianthus Therapeutics Inc. (DNTH)
NASDAQ · Healthcare
Dianthus Therapeutics Inc. Operating Income 2016–2025
Dianthus Therapeutics Inc. annual/quarterly operating income history and growth rate from 2016 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Dianthus Therapeutics Inc. operating income for the quarter ending September 30, 2025 was -40.3 M, a 34.74% increase year-over-year.
- Dianthus Therapeutics Inc. operating income for the twelve months ending September 30, 2025 was -138.3 M, a 115.88% increase year-over-year.
- Dianthus Therapeutics Inc. annual operating income for 2025 was -177.9 M, a 74.68% increase from 2024.
- Dianthus Therapeutics Inc. annual operating income for 2024 was -101.9 M, a 111.45% increase from 2023.
- Dianthus Therapeutics Inc. annual operating income for 2023 was -48.2 M, a 41.94% decrease from 2019.
- Dianthus Therapeutics Inc. annual operating income for 2019 was -83.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Dianthus Therapeutics Inc. Operating Income — FAQ
Dianthus Therapeutics Inc. (DNTH) operating income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Dianthus Therapeutics Inc.'s operating income?
Dianthus Therapeutics Inc. (DNTH) reported operating income of -$178M for fiscal 2025.
Where can I see DNTH's operating income history?
The chart and table above show Dianthus Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.